Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.700
-0.040 (-2.30%)
Jun 18, 2025, 2:10 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Protein Kinase Inhibitor Therapeutics
260.50K
Log In
Log In
Log In
Log In
Upgrade
Protein Kinase Inhibitor Therapeutics Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
United States
260.50K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade